http://www.hepatitis-central.com/mt/ Hepatitis C News, Updates and Commentary. Copyright 2008 Wed, 14 May 2008 09:25:03 -0500 http://www.movabletype.org/?v=3.16 http://blogs.law.harvard.edu/tech/rss This much-needed synopsis of alcoholic hepatitis reminds us that you don't need to be a heavy drinker to suffer from this condition. Looking over the causes, risk factors and complications of alcoholic hepatitis will motivate anyone with liver concerns to... http://www.hepatitis-central.com/mt/archives/2008/05/what_you_must_k.html http://www.hepatitis-central.com/mt/archives/2008/05/what_you_must_k.html General Hepatitis C News/Updates Wed, 14 May 2008 09:25:03 -0500 Finding new ways to manage the side effects of Hepatitis C combination therapy adds to a person’s likelihood of conquering the virus.... http://www.hepatitis-central.com/mt/archives/2008/05/15_tips_for_man.html http://www.hepatitis-central.com/mt/archives/2008/05/15_tips_for_man.html General Hepatitis C News/Updates Tue, 13 May 2008 11:12:26 -0500 Finally being recognized as the widespread, public health problem that it is, the New Mexico Department of Health has taken a giant step forward to help people with Hepatitis C. By launching a new, toll-free phone number, locals concerned about... http://www.hepatitis-central.com/mt/archives/2008/05/new_mexico_offe.html http://www.hepatitis-central.com/mt/archives/2008/05/new_mexico_offe.html General Hepatitis C News/Updates Mon, 12 May 2008 12:52:06 -0500 When tested on people with Hepatitis C genotype 1, R7128 proved to be an effective addition to combination therapy after just four weeks' time. In addition to its anti-viral effect, polymerase inhibitor R7128 received good marks for safety and minimal... http://www.hepatitis-central.com/mt/archives/2008/05/r7128_highly_ef.html http://www.hepatitis-central.com/mt/archives/2008/05/r7128_highly_ef.html Emerging Hepatitis C Treatments/Therapies Thu, 01 May 2008 14:01:21 -0500 A Phase IIa trial investigating triple combination therapy with PEGASYS, COPEGUS and Roche's investigational drug R1626, demonstrated a higher response rate than traditional combination therapy alone. While R1626's effectiveness and high barrier to resistance makes it a top Hepatitis C... http://www.hepatitis-central.com/mt/archives/2008/04/investigational.html http://www.hepatitis-central.com/mt/archives/2008/04/investigational.html Emerging Hepatitis C Treatments/Therapies Wed, 30 Apr 2008 14:26:01 -0500 A four-year study confirms that low-dosage maintenance interferon therapy prevents disease progression in those with portal hypertension or cirrhosis from Hepatitis C.... http://www.hepatitis-central.com/mt/archives/2008/04/hepatitis_c_com_1.html http://www.hepatitis-central.com/mt/archives/2008/04/hepatitis_c_com_1.html General Hepatitis C News/Updates Tue, 29 Apr 2008 14:15:42 -0500 Currently approved for treating contagious diarrhea in children, nitazoxanide has been found to make pegylated interferon-based treatment for Hepatitis C genotype 4 more effective. Prompting new trials in the U.S. and Europe, this drug is now being evaluated for Hepatitis... http://www.hepatitis-central.com/mt/archives/2008/04/nitazoxanide_im.html http://www.hepatitis-central.com/mt/archives/2008/04/nitazoxanide_im.html Emerging Hepatitis C Treatments/Therapies Tue, 29 Apr 2008 13:57:39 -0500 New research was presented at the American Association for Cancer Research supporting the use of Lapatinib for those with advanced liver cancer. Although currently approved for treating breast cancer, this drug represents hope for those who have progressed from chronic... http://www.hepatitis-central.com/mt/archives/2008/04/lapatinib_stabi.html http://www.hepatitis-central.com/mt/archives/2008/04/lapatinib_stabi.html Mon, 28 Apr 2008 14:03:32 -0500 Researchers from Oklahoma have revealed that a drug commonly prescribed for high cholesterol also lowers Hepatitis C viral load. Although not capable of clearing Hepatitis C on its own, a Phase II trial will reveal its effectiveness in combination with... http://www.hepatitis-central.com/mt/archives/2008/04/fluvastatin_low.html http://www.hepatitis-central.com/mt/archives/2008/04/fluvastatin_low.html Emerging Hepatitis C Treatments/Therapies Fri, 18 Apr 2008 10:20:04 -0500 Due to phase II safety trial results, Wyeth Pharmaceuticals and ViroPharma Inc. agreed to discontinue developing their Hepatitis C drug HCV-796. Executives report that HCV-796's capacity to inflict liver damage was too great to maintain its candidacy.... http://www.hepatitis-central.com/mt/archives/2008/04/hope_for_hcv_dr.html http://www.hepatitis-central.com/mt/archives/2008/04/hope_for_hcv_dr.html General Hepatitis C News/Updates Fri, 18 Apr 2008 10:13:02 -0500 The warmer weather is here and so are those pesky flies and insects. Learn if you should be worried about being infected with viral hepatitis from insect bites.... http://www.hepatitis-central.com/mt/archives/2008/04/can_insect_bite.html http://www.hepatitis-central.com/mt/archives/2008/04/can_insect_bite.html General Hepatitis C News/Updates Thu, 17 Apr 2008 16:04:25 -0500 Even though you may be on a first name basis with your general practitioner, research from Germany proves that your chances for successfully eliminating the Hepatitis C virus are greater when treated by a hepatologist.... http://www.hepatitis-central.com/mt/archives/2008/04/the_necessity_o.html http://www.hepatitis-central.com/mt/archives/2008/04/the_necessity_o.html General Hepatitis C News/Updates Thu, 17 Apr 2008 13:50:32 -0500 Of special interest for those who have relapsed after Hepatitis C pegylated interferon therapy: Medical experts are gaining insight into why some courses of treatment are unsuccessful. By aiming to eliminate the likely causes for previous failures, more non-responders may... http://www.hepatitis-central.com/mt/archives/2008/04/factors_improvi.html http://www.hepatitis-central.com/mt/archives/2008/04/factors_improvi.html General Hepatitis C News/Updates Mon, 07 Apr 2008 14:32:56 -0500 Scientists have discovered a unique property of a segment of one of Hepatitis C's proteins - inhibition of HIV. Continued research on this Hepatitis C component could lead to a new therapy capable of preventing HIV from being sexually transmitted.... http://www.hepatitis-central.com/mt/archives/2008/04/hepatitis_c_pro.html http://www.hepatitis-central.com/mt/archives/2008/04/hepatitis_c_pro.html General Hepatitis C News/Updates Fri, 04 Apr 2008 15:47:27 -0500 In addition to demonstrating a Hepatitis C anti-viral effect, an early trial investigating ITMN-191 met safety goals. With this good news, a Phase II study will evaluate this drug in combination with pegylated interferon and ribavirin.... http://www.hepatitis-central.com/mt/archives/2008/04/hepatitis_c_dru_1.html http://www.hepatitis-central.com/mt/archives/2008/04/hepatitis_c_dru_1.html Emerging Hepatitis C Treatments/Therapies Fri, 04 Apr 2008 15:27:22 -0500